Skip to main
SEM
SEM logo

SEM Stock Forecast & Price Target

SEM Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 45%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Select Medical Holdings Corp demonstrated robust financial performance, with the inpatient rehabilitation facility (IRF) segment achieving a 19% year-over-year growth in adjusted EBITDA to $63.8 million and a margin expansion of 90 basis points. The outpatient rehabilitation segment also showed positive metrics, with adjusted EBITDA rising 7.5% year-over-year to $28.3 million, bolstered by a stable demand for rehabilitation services. Additionally, the overall company is adjusting its 2025 adjusted EBITDA estimate upward to $938.1 million, reflecting strong topline growth and anticipated margin improvements across its segments, particularly if the company successfully navigates regulatory challenges.

Bears say

The financial analysis of Select Medical Holdings Corp indicates a concerning trend, with a 6% year-over-year decline in adjusted EBITDA for the Critical Illness Recovery Hospitals (CIRH) segment, alongside an 80 basis points contraction in margins to 8.3%. Furthermore, the company's occupancy rate fell by 200 basis points to 82%, attributed to the opening of new hospitals, suggesting potential overcapacity and diminished demand. Additionally, prolonged labor pressures are expected to result in FY25 EBITDA-MI being 10% below prior estimates, highlighting continued operational challenges and financial strain.

SEM has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 45% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Select Medical Holdings Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Select Medical Holdings Corporation (SEM) Forecast

Analysts have given SEM a Buy based on their latest research and market trends.

According to 11 analysts, SEM has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27.45, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Select Medical Holdings Corporation (SEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.